Memorial Sloan Kettering Cancer Center; Clinical Trials Office
New York, New York, United States
Hospital in New York City, New York
1275 York Ave, New York, NY 10065
498 (2018) Beds
About Memorial Sloan Kettering Cancer Center; Clinical Trials Office
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in the borough of Manhattan in New York City, founded in 1884 as the New York Cancer Hospital.
There are 498 (2018) beds in Memorial Sloan Kettering Cancer Center; Clinical Trials Office.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Memorial Sloan Kettering Cancer Center; Clinical Trials Office
During the past decade, Memorial Sloan Kettering Cancer Center; Clinical Trials Office conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
2000-01-01
2010-03-01
Terminated
589
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
2000-05-19
2010-01-27
Completed
3,436
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office"
#1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Memorial Sloan Kettering Cancer Center; Clinical Trials Office
According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" are
"Chronic Lymphocytic Leukemia" (1 trials), "Myelogenous Leukemia, Chronic" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" in a lesser frequency.
Clinical Trials Intervention Types at Memorial Sloan Kettering Cancer Center; Clinical Trials Office
Most popular intervention types in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Bendamustine" (1 trials), "PF-06671008" (1 trials), "Rituximab" (1 trials), "Venetoclax" (1 trials) and "imatinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Memorial Sloan Kettering Cancer Center; Clinical Trials Office
The vast majority of trials in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" are
3 trials for "All" genders.
Clinical Trials Status at Memorial Sloan Kettering Cancer Center; Clinical Trials Office
Currently, there are NaN active trials in "Memorial Sloan Kettering Cancer Center; Clinical Trials Office".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Memorial Sloan Kettering Cancer Center; Clinical Trials Office,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Memorial Sloan Kettering Cancer Center; Clinical Trials Office, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".